£77.91

Springer Spheroids in Cancer Research: Methods and Perspectives: 95 (Recent Results in Cancer Research, 95)

Price data last checked 35 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£78 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days • 56 data points (No recent data available)

Historical
Generating forecast...
£77.92 £77.91 £77.91 £77.91 £77.92 £77.92 £77.92 05 April 2026 18 April 2026 02 May 2026 16 May 2026 30 May 2026

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £78 Days at Price

Price Analysis

Most common price: £78 (56 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 56 days

Description

Malignant growth of cells is often characterized by disorganization of tissue structure, abnormal blood vessel development, and insuffi cient vascular supply. As a consequence, the cancer cells grow in a three-dimensional pattern in atypical microenvironments which include physical, chemical, and nutritional stresses. Necrosis often develops some distance away from the blood vessels. In association with an inherent instability in malignant cell populations, and also because of the changing micromilieu, significant cellular heteroge neity emerges with regard to various phenotypic characteristics. Both biological behavior and responses to therapeutic agents can be affected. A variety of in vitro and in vivo experimental models exist for research on properties of cancer cells during growth. The multicell spheroid model was developed as a system of intermediate complexity in which three dimensional growth of cells enhances cell-cell interactions and creates micro environments that simulate the conditions in intervascular microregions of tumors or microme tastatic foci. Spheroids may change their cellular characteristics with changing environments during growth. These can be studied under controlled conditions in vitro. Interest in details of experimental methods for this model system stimulated the organization of the First International Conference in Rochester, NY in 1980, the Proceedings of which were summarized in Cancer Research in 1981. Since then there has been a rapid increase in the use of this model system, and increased research on the significance of cell-cell and cell-microenvironment interactions in biology in general.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 December 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
81% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 19 May 2026
Cell-Extracellular Matrix Interactions in Cancer
81% match

Cell-Extracellular Matrix Interactions in Cancer

Springer

£107.98 25 May 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
81% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 21 May 2026
Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)
81% match

Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)

Springer

£112.85 05 Jun 2026
Systems Biology of Tumor Microenvironment: Quantitative Modeling and Simulations: 936 (Advances in Experimental Medicine and Biology, 936)
81% match

Systems Biology of Tumor Microenvironment: Quantitative Modeling and Simulations: 936 (Advances in Experimental Medicine and Biology, 936)

Springer

£108.31 24 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
80% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 31 May 2026
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)
80% match

Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention: 1 (Cancer Metastasis - Biology and Treatment, 1)

Springer

£110.24 25 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
80% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 29 May 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
79% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 11 Jun 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
79% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
79% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
79% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.14 30 May 2026
New Topics in Cancer Research (Horizons in Cancer Research)
79% match

New Topics in Cancer Research (Horizons in Cancer Research)

Brand: Nova Biomedical Books

£140.62 31 May 2026
Advances in Cancer Stem Cell Biology
79% match

Advances in Cancer Stem Cell Biology

Springer

£107.98 01 Jun 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
79% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)
79% match

Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)

Springer

£125.96 05 Jun 2026
Vesicle Trafficking in Cancer
79% match

Vesicle Trafficking in Cancer

Springer

£107.98 05 Jun 2026
Cancer Systems Biology: 32 (Chapman & Hall/CRC Computational Biology Series)
79% match

Cancer Systems Biology: 32 (Chapman & Hall/CRC Computational Biology Series)

CRC Press

£96.08 21 May 2026
The Role of Microenvironment in the Control of Tumor Angiogenesis
79% match

The Role of Microenvironment in the Control of Tumor Angiogenesis

Springer

£86.87 01 Jun 2026
Pharmaceutical Perspectives of Cancer Therapeutics
79% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 06 Jun 2026
Systems Biology in Cancer Research and Drug Discovery
79% match

Systems Biology in Cancer Research and Drug Discovery

Springer

£107.98 24 May 2026
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
79% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 17 May 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
79% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026